Seeing Is Believing
JANX is currently covered by 2 analysts with an average price target of $71.34. This is a potential upside of $22.38 (45.71%) from yesterday's end of day stock price of $48.96.
Janux Therapeutics's activity chart (see below) currently has 1 price targets and 16 ratings on display. The stock rating distribution of JANX is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 70.71% with an average time for these price targets to be met of 271.5 days.
Highest price target for JANX is $74, Lowest price target is $63, average price target is $71.34.
Most recent stock forecast was given by SWAYAMPAKULA RAMAKANTH from HC WAINWRIGHT on 07-Nov-2024. First documented stock forecast 13-Mar-2023.
Currently out of the existing stock ratings of JANX, 16 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$63
$14.24 (29.20%)
$63
14 days ago
(07-Nov-2024)
7/10 (70%)
$7.24 (12.98%)
311
Buy
$74
$25.24 (51.76%)
$74
3 months 13 days ago
(08-Aug-2024)
5/7 (71.43%)
$37.51 (102.80%)
232
What is JANX (Janux Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on JANX (Janux Therapeutics) with a proven track record?
Which analyst has the current lower performing score on JANX (Janux Therapeutics) with a proven track record?
Which analyst has the most public recommendations on JANX (Janux Therapeutics)?
Which analyst is the currently most bullish on JANX (Janux Therapeutics)?
Which analyst is the currently most reserved on JANX (Janux Therapeutics)?